GSA CAPITAL PARTNERS LLP - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 91 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2023$819
-99.9%
21,852
-36.5%
0.08%
-22.9%
Q1 2021$631,000
+25.2%
34,425
+4.3%
0.10%
+320.0%
Q2 2018$504,000
+26.0%
33,000
+47.3%
0.02%
-7.4%
Q3 2017$400,000
-61.6%
22,400
-60.4%
0.03%
-56.5%
Q4 2016$1,042,000
+203.8%
56,544
+212.4%
0.06%
+244.4%
Q3 2016$343,000
+109.1%
18,100
+57.4%
0.02%
+125.0%
Q4 2015$164,000
+12.3%
11,500
-7.9%
0.01%
+14.3%
Q3 2015$146,000
-32.1%
12,486
-13.3%
0.01%
-22.2%
Q1 2015$215,000
-38.9%
14,400
-52.5%
0.01%
-64.0%
Q4 2014$352,00030,3000.02%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2015
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$3,649,6053.75%
SHAKER INVESTMENTS LLC/OH 81,287$2,277,6621.41%
Mesirow Institutional Investment Management, Inc. 374,414$10,491,0801.38%
OBERWEIS ASSET MANAGEMENT INC/ 134,000$3,754,6800.80%
Portolan Capital Management 270,791$7,587,5640.75%
Hillsdale Investment Management Inc. 172,238$4,826,1090.41%
Capital Impact Advisors, LLC 14,669$411,0250.40%
Watershed Asset Management, L.L.C. 9,555$267,7310.34%
Quantedge Capital Pte Ltd 35,153$984,9870.33%
FEDERATED HERMES, INC. 3,284,217$92,023,7600.25%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders